TBIO
Translate Bio, Inc. Common Stock
TBIO
TBIO
Delisted
TBIO was delisted on the 13th of September, 2021.
146 hedge funds and large institutions have $1.1B invested in Translate Bio, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 62 increasing their positions, 42 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
64% less call options, than puts
Call options by funds: $5.01M | Put options by funds: $13.8M
Holders
146
Holding in Top 10
2
Calls
$5.01M
Puts
$13.8M
Top Buyers
| 1 | +$23.1M | |
| 2 | +$19M | |
| 3 | +$15.8M | |
| 4 |
Goldman Sachs
New York
|
+$10.1M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
+$9.84M |
Top Sellers
| 1 | -$25.1M | |
| 2 | -$12.9M | |
| 3 | -$6.43M | |
| 4 |
AG
Artal Group
Luxembourg
|
-$3.3M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$3.26M |